Featured Resources
-
Guidance on Implementability
This document provides guidance on the planning, design and conduct and reporting of clinical trials, so that the results from late-phase clinical trials are optimised for implementability.
-
Consumer Involvement and Engagement Toolkit
The Consumer Involvement and Engagement Toolkit provides practical advice for researchers and research organisations wishing to conduct patient-centred clinical trials.
-
COVID-19
We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.
Search Resources
General search and filters
Filter by:
Topics
Type of Resource
Results filtered by:
Official Opening of the 2020 ACTA Summit: Minister’s Address
Data and Safety Monitoring Boards Webinar Series: Statistical Principles
Data and Safety Monitoring Boards Webinar Series: How to plan well and be prepared for the unexpected
AAAPC Conference: ACTA Workshop Minutes
Statistical Analysis Plan
External Contractor Tender: Application of altered or waived consent approaches in low risk clinical trials
Improving impact of clinical trials through implementability
ACTA Board Charter
ACTA Constitution
Registry Randomised Trial Workshop Biographies
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
Applying a proportionate approach to consent in comparative effectiveness trials